Praxis Precision Medicines Reports Positive Results From PRAX-628 Study - Quick Facts

(RTTNews) - Praxis Precision Medicines, Inc. (PRAX) issued an update on Phase 2a proof of concept study evaluating PRAX-628 in epilepsy patients w...

Related Keywords

Marcio Souza , More Such Health News , Praxis Precision Medicines Inc , Precision Medicines , Photo Paroxysmal Response ,